Bank of America’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bank of America’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,276,800	Closed	-$128M	–	8432
2025 Q3	$128M	Sell	1,276,800 -20,000	-2%	-$1.8M	0.01%	1058
2025 Q2	$108M	Buy	1,296,800 +667,300	+106%	+$53.2M	0.01%	1105
2025 Q1	$51.1M	Sell	629,500 -103,500	-14%	-$9.25M	﹤0.01%	1567
2024 Q4	$66M	Sell	733,000 -358,800	-33%	-$34.8M	0.01%	1294
2024 Q3	$108M	Buy	1,091,800 +120,600	+12%	+$11.8M	0.01%	1024
2024 Q2	$90M	Sell	971,200 -76,600	-7%	-$6.87M	0.01%	1074
2024 Q1	$99.4M	Buy	1,047,800 +602,400	+135%	+$55.9M	0.01%	1018
2023 Q4	$39.8M	Sell	445,400 -54,600	-11%	-$4.05M	﹤0.01%	1535
2023 Q3	$36.5M	Buy	+500,000	New	+$39.9M	﹤0.01%	1499
2023 Q2	–	Sell	-125,200	Closed	-$9.54M	–	7979
2023 Q1	$9.54M	Sell	125,200 -466,800	-79%	-$38.7M	﹤0.01%	2870
2022 Q4	$49.1M	Buy	592,000 +48,900	+9%	+$3.96M	0.01%	1315
2022 Q3	$43.1M	Buy	543,100 +296,200	+120%	+$25M	0.01%	1365
2022 Q2	$18.3M	Buy	246,900 +71,900	+41%	+$5.4M	﹤0.01%	2092
2022 Q1	$15.7M	Buy	175,000 +139,500	+393%	+$12.9M	﹤0.01%	2396
2021 Q4	$3.98M	Sell	35,500 -160,600	-82%	-$19.4M	﹤0.01%	3888
2021 Q3	$24.7M	Sell	196,100 -643,600	-77%	-$82.9M	﹤0.01%	1987
2021 Q2	$114M	Sell	839,700 -882,200	-51%	-$116M	0.01%	884
2021 Q1	$234M	Buy	1,721,900 +1,671,900	+3,344%	+$250M	0.03%	523
2020 Q4	$7.04M	Sell	50,000 -165,700	-77%	-$21.2M	﹤0.01%	2830
2020 Q3	$24M	Buy	215,700 +10,400	+5%	+$1.17M	﹤0.01%	1561
2020 Q2	$23M	Sell	205,300 -17,700	-8%	-$1.74M	﹤0.01%	1519
2020 Q1	$17.3M	Buy	+223,000	New	+$19.7M	﹤0.01%	1623
2019 Q4	–	Sell	-231,800	Closed	-$17.7M	–	7441
2019 Q3	$17.7M	Buy	231,800 +114,900	+98%	+$9.55M	﹤0.01%	1937
2019 Q2	$10.3M	Sell	116,900 -30,000	-20%	-$2.56M	﹤0.01%	2529
2019 Q1	$13.3M	Buy	146,900 +146,500	+36,625%	+$12.5M	﹤0.01%	2204
2018 Q4	$29K	Buy	+400	New	+$32.2K	﹤0.01%	6393
2018 Q3	–	Sell	-1,467,500	Closed	-$140M	–	7500
2018 Q2	$140M	Buy	+1,467,500	New	+$135M	0.02%	566
2018 Q1	–	Sell	-200,000	Closed	-$17M	–	7373
2017 Q4	$17M	Buy	+200,000	New	+$16.8M	﹤0.01%	1955
2017 Q2	–	Sell	-295,600	Closed	-$20.5M	–	7200
2017 Q1	$20.5M	Sell	295,600 -169,600	-36%	-$11.4M	﹤0.01%	1721
2016 Q4	$27.5M	Buy	465,200 +45,200	+11%	+$2.79M	0.01%	1418
2016 Q3	$27.8M	Buy	420,000 +320,000	+320%	+$19.8M	0.01%	1397
2016 Q2	$5.41M	Buy	100,000 +50,000	+100%	+$2.74M	﹤0.01%	2740
2016 Q1	$2.58M	Buy	+50,000	New	+$2.6M	﹤0.01%	3351

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Bank of America's XBI Position: Q1 2026 in Review

Bank of America increased its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q1 2026, buying an estimated $212M and bringing the position to 14,518,027 shares worth $1.85B. The position accounts for 0.14% of the portfolio, ranked #161.

Bank of America first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Bank of America held 14,518,027 shares of State Street SPDR S&P Biotech ETF worth $1.85B as of Q1 2026.
Bank of America bought 1,700,851 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $212M.
State Street SPDR S&P Biotech ETF made up 0.14% of Bank of America's portfolio in Q1 2026, its #161 holding.
Bank of America first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.